Experimental animal and clinical studies have well established the association of prenatal exposure to diethylstilbestrol (DES) and the subsequent development of reproductive tract abnormalities, including poor reproductive outcome and neoplasia. Overwhelmingly, the focus has been on DES-induced epithelial lesions, particularly vaginal adenosis and adenocarcinoma; however, uterine smooth muscle cells are also recognized as cellular targets of DES. This descriptive report characterizes uterine leiomyoma s that occur in outbred CD-1 mice following exposure to DES prenatally on days 9 to 16 of gestation or on neonatal days 1 to 5. These DES-induced uterine leiomyomas have typical histomorphologic, and some immunohistochemica l characteristics of spontaneously occurring uterine smooth muscle tumors of B6C3F1 mice previously described in our laboratory, and they are also similar to uterine leiomyomas (fibroids) commonly observed in premenopausal women.
Aoyama H., Kato H., Dixon D. (1997). Specificity of antibodies against rodent transforming growth factor-α protein. J Histochem Cytochem45: 695—701.
2.
Branham WS, Zehr DR, Chen JJ, Sheehan DM (1988). Alterations in developing rat uterine cell populations after neonatal exposure to estrogens and antiestrogens. Teratology38: 271—279.
3.
. Brody JR, Cunha GR (1989). Histologic, morphometric, and immunocytochemical analysis of myometrial development in rats and mice II. Effects of DES on development. Am J Anat186: 21—42.
4.
Colborn T., Clement C. (1992). Chemically-Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton Scientific Publishing Co., Princeton, NJ.
5.
Colborn T., Dumanski D., Myers JP (1996). Our Stolen Future. Penguin Books, New York, pp 1—294.
6.
Colborn T., vorn Saal FS, Soto AM ( 1993). Developmental effects of endocrine disrupting chemicals in wildlife and humans. Environ Health Perspect101: 378—384.
7.
Cramer SF, Patel A. (1990). The frequency of uterine leiomyomas. Am J Clin Pathol94: 435—438.
8.
Crum C., Cotran RS, Kumar V., Collins T. (1999). The female genital tract. In: Pathologic Basis of Disease, 6th edition, Cotran, Kumar, Collins (eds). WB Saunders, Philadelphia, PA, pp 1035—1091.
9.
Dixon D., Flake GP, Moore AB, He H., Haseman JK, Risinger JI, Lancaster JM, Berchuck A., Barrett JC, Robboy SJCell proliferation and apoptosis in human uterine leiomyomas and myometriaVirchows Archiv441: 53—62.
10.
Dixon D., He H., Haseman JK (2000). Immunohistochemica l localization of growth factors and their receptors in uterine leiomyomas and myometrium. Environ Health Perspect108(5): 795—802.
11.
Greenwell A. , Foley JF, Maronpot RR (1991). An enhancement method for immunohistochemical staining of proliferating cell nuclear antigen in archival rodent tissues. Cancer Lett59: 251—256.
12.
Herbst AL, Bern HA ( 1981). Developmental Effects of Diethylstilbestrol (DES) in Pregnancy. Thieme-Stratton, New York.
13.
Herbst AL, Ulfelder H., Poskanzer DC (1971). Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med284: 878—881.
14.
Kirkman H., Algard FT (1970). Characteristics of an androgen-estrogen- induced uterine smooth muscle cell tumor of the Syrian hamster. Cancer Res30: 794—800.
15.
Leavitt WW, Evans RW, Hendry WJ (1981). Etiology of DES-induced uterine tumors in the Syrian Hamster. Adv Exp Mol Biol138: 63—86.
16.
McLachlan JA (1985). Estrogens in the Environment II: Influences on Development. Elsevier Press, New York.
17.
McLachlan JA , Newbold RR, Bullock BC (1980). Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol . Cancer Res40: 3988—3999.
18.
McLachlan JA , Newbold RR, Shah HC, Hogan MD, Dixon RL (1982). Reduced fertility in female mice exposed transplacentally to diethylstilbestrol (DES). Fertil Steril38(3): 364—371.
19.
Moore AB, He H., Yoshida A., Rico PJ, Haseman JK, Dixon D. (2000). Transforming growth factor-alpha, epidermal growth factor receptor, and PCNA immunoexpression in uterine leiomyosarcomas and leiomyomas in B6C3F1 mice. Exp Toxic Pathol52: 195—200.
20.
Newbold RR (1995). Cellular and molecular effects of developmental exposure to diethylstilbestrol: Implications for other environmental estrogens . Environ Health Perspect103: 83—87.
21.
Newbold RR, Bullock BC, McLachlan JA (1990). Uterine adenocarcinom a in mice following developmental treatment with estrogens: A model for hormonal carcinogenesis. Cancer Res50: 7677—7681.
22.
Newbold RR, McLachlan JA (1982). Vaginal adenosi s and adenocarcinom a in mice exposed prenatally or neonatally to diethylstilbestrol. Cancer Res42: 2003—2011.
23.
Newbold RR, McLachlan JA (1985). Diethylstilbestrol associated defects in murine genital tract development. In: Estrogens in the Environment , McLachlan JA (ed). Elsevier Science, New York, pp 288—318.
24.
Newbold RR, Tyrey S., Haney AF, McLachlan JA (1983). Developmentally arrested oviduct: A structural and functional defect in mice following prenatal exposure to diethylstilbestrol . Teratology27: 417—426.
25.
. NIHPublicationNo. 00-4722(1999). DES Researchupdate:Currentknowledge, future directions. National Institute of Health, Bethesda, Maryland.
26.
Porter KB, Tsibris JC, Nicosia SV, Murphy JM, O'Brien WF, Rao PS, Spellacy WN (1995). Estrogen-induced guinea pig model for uterine leiomyomas: Do the ovaries protect? Biol Reprod52: 824—832.
27.
Rosenthal A. , Linquist PB, Bringman TS, Goeddel DV, Derynck R. (1986). Expression in rat fibroblasts of a human transforming growth factor-α results in transformation. Cell46: 301—309.
28.
Tsutsui T., Barrett JC (1997). Neoplastic transformation of cultured mammalian cells by estrogens and estrogenlike chemicals. Environ Health Perspec105(3): 619—624.
29.
Yoshida A., Newbold RR, Dixon D. (1999). Effects of neonatal diethylstilbestrol (DES) exposure on morphology and growth patterns of endometrial epithelial cells in CD-1 mice. Toxicol Pathol27: 325—333.
